Bicara Therapeutics Inc. (BCAX) Stock Forecast 2027–2031
BCAX Price Today
$9.13
BCAX Stock Ratings
BCAX Price Targets
| Month | Close | Total,% |
|---|---|---|
| 2026 | ||
| Nov | $9.24 | 1.20% |
| Dec | $9.31 | 1.97% |
| 2027 | ||
| Jan | $9.34 | 2.30% |
| Feb | $9.28 | 1.64% |
| Mar | $9.31 | 1.97% |
| Apr | $9.38 | 2.74% |
| May | $9.35 | 2.41% |
| Jun | $9.30 | 1.86% |
| Jul | $9.35 | 2.41% |
| Aug | $9.29 | 1.75% |
| Sep | $9.17 | 0.44% |
| Oct | $9.19 | 0.66% |
| Nov | $9.30 | 1.86% |
| Dec | $9.36 | 2.52% |
| 2028 | ||
| Jan | $9.40 | 2.96% |
| Feb | $9.33 | 2.19% |
| Mar | $9.37 | 2.63% |
| Apr | $9.44 | 3.40% |
| May | $9.40 | 2.96% |
| Jun | $9.36 | 2.52% |
| Jul | $9.41 | 3.07% |
| Aug | $9.35 | 2.41% |
| Sep | $9.22 | 0.99% |
| Oct | $9.24 | 1.20% |
| Nov | $9.35 | 2.41% |
| Dec | $9.42 | 3.18% |
| 2029 | ||
| Jan | $9.46 | 3.61% |
| Feb | $9.39 | 2.85% |
| Mar | $9.43 | 3.29% |
| Apr | $9.50 | 4.05% |
| May | $9.46 | 3.61% |
| Jun | $9.41 | 3.07% |
| Jul | $9.47 | 3.72% |
| Aug | $9.41 | 3.07% |
| Sep | $9.28 | 1.64% |
| Oct | $9.30 | 1.86% |
| Nov | $9.41 | 3.07% |
| Dec | $9.48 | 3.83% |
| 2030 | ||
| Jan | $9.52 | 4.27% |
| Feb | $9.45 | 3.50% |
| Mar | $9.48 | 3.83% |
| Apr | $9.55 | 4.60% |
| May | $9.52 | 4.27% |
| Jun | $9.47 | 3.72% |
| Jul | $9.53 | 4.38% |
| Aug | $9.46 | 3.61% |
| Sep | $9.33 | 2.19% |
| Oct | $9.35 | 2.41% |
| Nov | $9.47 | 3.72% |
| Dec | $9.53 | 4.38% |
| 2031 | ||
| Jan | $9.57 | 4.82% |
| Feb | $9.50 | 4.05% |
| Mar | $9.54 | 4.49% |
| Apr | $9.61 | 5.26% |
| May | $9.57 | 4.82% |
| Jun | $9.53 | 4.38% |
| Jul | $9.58 | 4.93% |
| Aug | $9.52 | 4.27% |
| Sep | $9.39 | 2.85% |
| Oct | $9.41 | 3.07% |
The BCAX stock price forecast for 2026 is $9.31, which is a change of +1.97% over today.
The BCAX stock price forecast for 2027 is $9.38, which is a change of +2.74% over today.
The BCAX stock price forecast for 2028 is $9.44, which is a change of +3.40% over today.
The BCAX stock price forecast for 2029 is $9.50, which is a change of +4.05% over today.
The BCAX stock price forecast for 2030 is $9.55, which is a change of +4.60% over today.
The BCAX stock price forecast for 2031 is $9.61, which is a change of +5.26% over today.
Is BCAX Stock a Buy?
Is BCAX Stock a Good Long-Term Investment?
Can BCAX stock reach $200?
BCAX Frequently Asked Questions
What is BCAX stock rated?
Wall Street X rates BCAX a HOLD, and the average consensus rating is a BUY.
What is the price target for BCAX?
Wall Street X has a one year price target of $9.19 for BCAX.
How do I buy shares of BCAX?
To buy shares of BCAX, open an account with an online brokerage, deposit money from your bank, search for “BCAX”, choose the number of shares or dollar amount, and place a trade.
Popular Articles
BCAX forecast data was last updated on by .
Bookmark this page to check for updates:
on iPhone/iPad tap the Share icon 
. Select Add to Favorites, then Add.
on Android tap the 3-dots icon 
at the top right. Tap Add to Favorites, then Add.
on PC press buttons Ctrl + D or click the star 
next to the browser bar at the top.
Trending Stocks This Week
| Loading… |
JOIN OUR NEWSLETTER WAITLIST
Daily trending stocks, portfolio updates, upgrades/downgrades, and latest articles.
BCAX Price Target Calculator
Interactive calculatorAdjust growth and future valuation assumptions to estimate a stock price target.
Stock target = Current price × (1 + annual compounded revenue growth)selected years × (future P/S ÷ current P/S)selected years ÷ selected period. The default annual growth is solved from the final The BCAX stock price forecast for 2026 is $9.31, which is a change of +1.97% over today. The BCAX stock price forecast for 2027 is $9.38, which is a change of +2.74% over today. The BCAX stock price forecast for 2028 is $9.44, which is a change of +3.40% over today. The BCAX stock price forecast for 2029 is $9.50, which is a change of +4.05% over today. The BCAX stock price forecast for 2030 is $9.55, which is a change of +4.60% over today. The BCAX stock price forecast for 2031 is $9.61, which is a change of +5.26% over today.
The red benchmark starts at the same current price and compounds at 10.4% annually. It is an illustrative comparison, not a prediction of S&P 500 returns. Calculations assume constant forecast growth, stable shares outstanding, and no dividends or dilution.
